NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway
- PMID: 12740575
- DOI: 10.1038/ni929
NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway
Abstract
The immune recognition receptor complex NKG2D-DAP10 on natural killer cells is stimulated by specific ligands carried on virus-infected and malignant cells. Because DAP10 does not have an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic tail, its ability to trigger killing has been debated. Here we show that a crucial Tyr-Ile-Asn-Met amino acid motif in the cytoplasmic tail of DAP10 couples receptor stimulation to the downstream activation of phosphatidylinositol 3-kinase, Vav1, Rho family GTPases and phospholipase C. Unlike that of ITAM-containing receptors, the activation of NKG2D-DAP10 proceeds independently of Syk family protein tyrosine kinases. Yet the signals initiated by NKG2D-DAP10 are fully capable of inducing killing. Our findings identify a previously unknown mechanism by which receptor complexes that lack ITAM motifs can trigger lymphocyte activation.
Comment in
-
The choices of a natural killer.Nat Immunol. 2003 Jun;4(6):509-10. doi: 10.1038/ni0603-509. Nat Immunol. 2003. PMID: 12774071 No abstract available.
Similar articles
-
NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases.Nat Immunol. 2003 Jun;4(6):565-72. doi: 10.1038/ni930. Epub 2003 May 11. Nat Immunol. 2003. PMID: 12740576
-
NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells.Nat Immunol. 2006 May;7(5):524-32. doi: 10.1038/ni1325. Epub 2006 Apr 2. Nat Immunol. 2006. PMID: 16582911
-
Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.J Immunol. 2006 Aug 15;177(4):2349-55. doi: 10.4049/jimmunol.177.4.2349. J Immunol. 2006. PMID: 16887996
-
NKG2D-mediated activation of cytotoxic lymphocytes: unique signaling pathways and distinct functional outcomes.Semin Immunol. 2006 Jun;18(3):167-75. doi: 10.1016/j.smim.2006.03.001. Epub 2006 May 24. Semin Immunol. 2006. PMID: 16723257 Review.
-
Up on the tightrope: natural killer cell activation and inhibition.Nat Immunol. 2008 May;9(5):495-502. doi: 10.1038/ni1581. Nat Immunol. 2008. PMID: 18425106 Free PMC article. Review.
Cited by
-
Research Progress on NK Cell Receptors and Their Signaling Pathways.Mediators Inflamm. 2020 Jul 24;2020:6437057. doi: 10.1155/2020/6437057. eCollection 2020. Mediators Inflamm. 2020. PMID: 32774149 Free PMC article. Review.
-
Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cells.MAbs. 2009 Mar-Apr;1(2):115-27. doi: 10.4161/mabs.1.2.7630. Epub 2009 Mar 11. MAbs. 2009. PMID: 20061825 Free PMC article.
-
Molecular regulation of the plasma membrane-proximal cellular steps involved in NK cell cytolytic function.J Cell Sci. 2020 Feb 21;133(5):jcs240424. doi: 10.1242/jcs.240424. J Cell Sci. 2020. PMID: 32086255 Free PMC article. Review.
-
Mutations in PI3K110δ cause impaired natural killer cell function partially rescued by rapamycin treatment.J Allergy Clin Immunol. 2018 Aug;142(2):605-617.e7. doi: 10.1016/j.jaci.2017.11.042. Epub 2018 Jan 10. J Allergy Clin Immunol. 2018. PMID: 29330011 Free PMC article.
-
CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway.Neurotherapeutics. 2021 Jul;18(3):1980-1994. doi: 10.1007/s13311-021-01038-1. Epub 2021 Apr 7. Neurotherapeutics. 2021. PMID: 33829411 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
